London Health Sciences Centre Announces Firsts In Treatment Option For Blood Circulation
Bernard Ross, CEO Firstkind Ltd, device manufacturer, said: "Precise management of fluids and electrolytes is a fundamental part of a patient's overall surgical treatment. Through the unique differential of superior blood flow, we believe the geko™ device is well placed to deliver simplicity of patient care, enhanced patient mobility, better patient outcomes and substantial cost savings for health services globally through a reduced length of patient stay."
About London Health Sciences Centre
London Health Sciences Centre has been in the forefront of medicine in Canada for 138 years and offers the broadest range of specialized clinical services in Ontario. Building on the traditions of its founding hospitals to provide compassionate care in an academic teaching setting, London Health Sciences Centre is home to Children's Hospital, University Hospital, Victoria Hospital, the Kidney Care Centre, two family medical centres, and two research institutes - Children's Health Research Institute and Lawson Health Research Institute, a joint research initiative with St. Joseph's Health Care London. As a leader in medical discovery and health research, London Health Sciences Centre has a history of over 65 international and national firsts and attracts top clinicians and researchers from around the world. As a regional referral centre, London Health Sciences Centre cares for the most medically complex patients including critically injured adults and children in southwestern Ontario and beyond. The hospital's nearly 15,000 staff, physicians, students and volunteers provide care for more than one million patient visits a year. For more information visit http://www.lhsc.on.caSOURCE London Health Sciences Centre and Firstkind Ltd
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts